1. Home
  2. ITOC vs BMRA Comparison

ITOC vs BMRA Comparison

Compare ITOC & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ITOC

iTonic Holdings Ltd Class A Ordinary Shares

N/A

Current Price

$0.31

Market Cap

5.0M

Sector

N/A

ML Signal

N/A

Logo Biomerica Inc.

BMRA

Biomerica Inc.

N/A

Current Price

$2.13

Market Cap

5.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ITOC
BMRA
Founded
1998
1971
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0M
5.0M
IPO Year
2023
1995

Fundamental Metrics

Financial Performance
Metric
ITOC
BMRA
Price
$0.31
$2.13
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
320.2K
183.6K
Earning Date
03-20-2026
04-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
39.81
EPS
N/A
N/A
Revenue
N/A
$4,453,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$1.45
52 Week High
$1.15
$3.21

Technical Indicators

Market Signals
Indicator
ITOC
BMRA
Relative Strength Index (RSI) 51.03 68.32
Support Level $0.29 $2.05
Resistance Level $0.36 $2.26
Average True Range (ATR) 0.03 0.19
MACD 0.00 0.04
Stochastic Oscillator 51.52 81.38

Price Performance

Historical Comparison
ITOC
BMRA

About ITOC iTonic Holdings Ltd Class A Ordinary Shares

iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its product, Beijing Feitian's Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors. Its product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device, etc.

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

Share on Social Networks: